Subthreshold micropulse laser delivers laser energy in short repeated pulses that heat the retinal pigment epithelium without a visible burn.
Clinicians use it for diabetic macular edema, vein occlusion edema, and some chronic serous disease, mainly near the fovea.
Because it avoids scars, it appeals when conventional laser would risk central vision.
How Subthreshold Micropulse Laser Works
Conventional laser uses a continuous wave that creates a visible burn and a scar.
In micropulse mode, the laser fires many tiny pulses with rest periods between them.
The duty cycle is the fraction of time that the laser is on, and it is usually 5 to 15 percent.
Because the tissue cools between pulses, heat spreads little, and the photoreceptors and neurosensory retina suffer minimal damage.
Researchers think that the effect comes from stimulating RPE cells to release factors that lower edema.
The exact mechanism is still debated, so treat the explanation as a working model.
Settings for Subthreshold Micropulse Laser
Platforms include 577 nm yellow and 810 nm diode systems.
Many clinicians test a threshold on a nearby area of retina with a continuous wave, then use a fraction of that energy in micropulse mode.
Common spot sizes are 160 to 200 micrometers, with a confluent pattern across the edematous area.
Settings differ by device, so follow the manufacturer’s guidance and local protocols (see panretinal photocoagulation for conventional laser comparison).
Fundus Explorer Pro
Photograph the retinal findings described here with the phone already in your pocket — 22 D optics and built-in illumination in one handheld unit.
From Choroida — the team behind this siteIndications
- Diabetic macular edema with center involvement and good vision
- Macular edema after branch retinal vein occlusion
- Chronic central serous disease, as a selected option
- Persistent edema after anti-VEGF therapy, as an adjunct
Evidence for Subthreshold Micropulse Laser
A meta-analysis of randomized trials found that micropulse laser matched conventional laser for diabetic macular edema and caused less retinal damage.
However, it was usually less effective than anti-VEGF injections for vision gain.
Studies vary in laser settings and follow-up, so pooled results carry uncertainty (see diabetic macular edema).
Advantages and Limits
The main advantage is safety, since it creates no scars and lets clinicians treat close to the fovea.
Treatment can be repeated if edema returns.
Disadvantages include the lack of a visible endpoint, the need for careful device training, and variable results.
Evidence for thick edema is weaker than for mild or moderate edema.
Safety Considerations
Complications are rare, though some eyes show faint pigment changes at high energy levels.
Check that the power stays low enough to avoid visible burns, and stop if a spot turns white.
Also use a contact lens with known magnification and keep the spot size consistent.

Practical Points
- Choose eyes with modest thickness and good vision
- Use OCT to follow the response at three months
- Combine with anti-VEGF drugs when edema is severe
- Explain that the benefit may appear slowly over weeks
An Example Case
A 62-year-old man with type 2 diabetes has center-involving macular edema with a central thickness of 380 micrometers and vision of 20/30.
He wants to avoid repeated injections because of travel limits.
After a discussion, he receives subthreshold micropulse laser across the thickened macula.
OCT at three months shows a small drop in thickness and stable vision.
He receives a second session at six months, and the macula stays stable for a year.
Subthreshold Micropulse Laser Versus Injections
Anti-VEGF drugs improve vision more often and work faster.
Micropulse laser avoids repeated injections, although it works more slowly and less strongly.
Therefore, many clinicians use it for mild edema, for patients who cannot attend often, or as an adjunct (see diabetic macular edema).
Pitfalls to Avoid
- Combine micropulse laser with injections in severe edema with poor vision
- Expect a slow response, which may take months
- Test the settings in a neutral area first
- Wait for the response before repeating treatment
Questions Patients Ask
Patients ask whether the laser hurts, and most feel little or nothing.
They also ask why they cannot see the treatment marks, and the answer is that the laser leaves no visible scars.
Explain that results vary and that injections may still be needed.
Also tell them that two or three sessions are common.
Key Points
Micropulse laser treats the retina without visible burns, so it suits eyes near the fovea.
Evidence shows safety and similarity to conventional laser, but weaker effects than anti-VEGF drugs.
Choose eyes with mild edema and good vision.
For the latest studies, see the PubMed results for subthreshold micropulse laser.


Document what you see
Two smartphone imaging tools built for everyday clinic use — one for the slit lamp, one for the fundus.
From Choroida — the team behind this siteReferences
- Chen G, Tzekov R, Li W, et al. Subthreshold micropulse diode laser versus conventional laser photocoagulation for diabetic macular edema: a meta-analysis of randomized controlled trials. Retina. 2016;36:2059-2065.
- Luttrull JK, Dorin G. Subthreshold diode micropulse laser photocoagulation (SDM) as invisible retinal phototherapy for diabetic macular edema: a review. Curr Diabetes Rev. 2012;8:274-284.
- Flaxel CJ, Adelman RA, Bailey ST, et al. Diabetic retinopathy preferred practice pattern. Ophthalmology. 2020;127:P66-P145.
- American Academy of Ophthalmology. Basic and Clinical Science Course, Section 12: Retina and Vitreous. AAO; current edition.
Test yourself
A few questions straight from this article.
-
What distinguishes subthreshold micropulse laser from conventional retinal laser?
Micropulse laser delivers energy in short repeated pulses that heat the retinal pigment epithelium without a visible burn, whereas conventional continuous-wave laser leaves a burn and scar. -
What is the usual duty cycle in subthreshold micropulse laser treatment?
The duty cycle is the fraction of time the laser is on, usually 5 to 15 percent in micropulse mode. -
Why does subthreshold micropulse laser cause minimal damage to the photoreceptors and neurosensory retina?
Because the tissue cools during the rest periods between pulses, heat spreads little and the photoreceptors and neurosensory retina suffer minimal damage. -
Which laser platforms are used for subthreshold micropulse treatment?
Micropulse platforms include 577 nm yellow and 810 nm diode systems, and settings differ by device. -
How do many clinicians set the energy for subthreshold micropulse laser?
Many clinicians test a threshold with continuous wave on a nearby retinal area, then use a fraction of that energy in micropulse mode. -
For diabetic macular edema, how did micropulse laser compare with conventional laser in a meta-analysis of randomized trials?
The meta-analysis found micropulse laser matched conventional laser for diabetic macular edema with less retinal damage, though it was usually less effective than anti-VEGF for vision gain. -
Which diabetic macular edema patient best suits subthreshold micropulse laser?
Indications include centre-involving diabetic macular edema with good vision; evidence is weaker for thick edema, where anti-VEGF is combined. -
Which practical disadvantage of subthreshold micropulse laser makes careful device training necessary?
Disadvantages include the lack of a visible endpoint, the need for careful device training and variable results; treatment can, however, be repeated. -
During subthreshold micropulse laser, what should prompt the clinician to stop?
Power should stay low enough to avoid visible burns, so treatment stops if a spot turns white; faint pigment changes can appear at high energies. -
When is OCT used to assess the response after subthreshold micropulse laser?
OCT follows the response at three months because the benefit appears slowly, so the response is awaited before repeating treatment.